Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Practice Pearls: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral drugs for type 2 diabetes that inhibit the breakdown of glucagon-like peptide-1 (GLP-1) and increase the release of insulin in response to a meal
doi: 10.1155/2018/9734845 43
Potential Side Effects While GLP-1 medications for diabetes are generally well tolerated, they can cause side effects, especially during the early stages of use
Related Stories The study from the Cleveland Clinic also found that it was 50% less likely for patients with stage 3 lung cancer that were taking GLP-1s to progress to stage 4 compared to those taking DPP-4 inhibitor, which is a class of oral medications used to treat Type 2 diabetes by helping the body release more insulin after meals, according to the outlet, which cited the study
Its very easy to do and I am starting to feel energetic, which was my main reason for using it
